55 related articles for article (PubMed ID: 18000367)
1. Disruption of the FA/BRCA pathway in bladder cancer.
Neveling K; Kalb R; Florl AR; Herterich S; Friedl R; Hoehn H; Hader C; Hartmann FH; Nanda I; Steinlein C; Schmid M; Tonnies H; Hurst CD; Knowles MA; Hanenberg H; Schulz WA; Schindler D
Cytogenet Genome Res; 2007; 118(2-4):166-76. PubMed ID: 18000367
[TBL] [Abstract][Full Text] [Related]
2. Identification of a Hypomorphic
Meek K; Yang YT; Takada M; Parys M; Richter M; Engleberg AI; Thaiwong T; Griffin RL; Schall PZ; Kramer AJ; Yuzbasiyan-Gurkan V
Genes (Basel); 2022 Sep; 13(10):. PubMed ID: 36292578
[TBL] [Abstract][Full Text] [Related]
3. Concurrent alterations in TERT, KDM6A, and the BRCA pathway in bladder cancer.
Nickerson ML; Dancik GM; Im KM; Edwards MG; Turan S; Brown J; Ruiz-Rodriguez C; Owens C; Costello JC; Guo G; Tsang SX; Li Y; Zhou Q; Cai Z; Moore LE; Lucia MS; Dean M; Theodorescu D
Clin Cancer Res; 2014 Sep; 20(18):4935-48. PubMed ID: 25225064
[TBL] [Abstract][Full Text] [Related]
4. Differential operation of MLH1/MSH2 and FANCD2 crosstalk in chemotolerant bladder carcinoma: a clinical and therapeutic intervening study.
Basu M; Mukhopadhyay D; Chakraborty B; Ghosh S; Pal DK; Ghosh A; Panda CK
Mol Cell Biochem; 2023 Jul; 478(7):1599-1610. PubMed ID: 36434146
[TBL] [Abstract][Full Text] [Related]
5. Distinctive mutational spectrum and karyotype disruption in long-term cisplatin-treated urothelial carcinoma cell lines.
Skowron MA; Petzsch P; Hardt K; Wagner N; Beier M; Stepanow S; Drechsler M; Rieder H; Köhrer K; Niegisch G; Hoffmann MJ; Schulz WA
Sci Rep; 2019 Oct; 9(1):14476. PubMed ID: 31597922
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of non-homologous end joining in Fanconi Anemia cells results in rescue of survival after interstrand crosslinks but sensitization to replication associated double-strand breaks.
Eccles LJ; Bell AC; Powell SN
DNA Repair (Amst); 2018 Apr; 64():1-9. PubMed ID: 29459202
[TBL] [Abstract][Full Text] [Related]
7. The expression of ERCC1 and BRCA1 predicts prognosis of platinum-based chemotherapy in urothelial cancer.
Song W; Ma H
Onco Targets Ther; 2016; 9():3465-71. PubMed ID: 27366083
[TBL] [Abstract][Full Text] [Related]
8. Veliparib Alone or in Combination with Mitomycin C in Patients with Solid Tumors With Functional Deficiency in Homologous Recombination Repair.
Villalona-Calero MA; Duan W; Zhao W; Shilo K; Schaaf LJ; Thurmond J; Westman JA; Marshall J; Xiaobai L; Ji J; Rose J; Lustberg M; Bekaii-Saab T; Chen A; Timmers C
J Natl Cancer Inst; 2016 Jul; 108(7):. PubMed ID: 26848151
[TBL] [Abstract][Full Text] [Related]
9. Inactivation of BRCA2 in human cancer cells identifies a subset of tumors with enhanced sensitivity towards death receptor-mediated apoptosis.
De Toni EN; Ziesch A; Rizzani A; Török HP; Hocke S; Lü S; Wang SC; Hucl T; Göke B; Bruns C; Gallmeier E
Oncotarget; 2016 Feb; 7(8):9477-90. PubMed ID: 26843614
[TBL] [Abstract][Full Text] [Related]
10. FANCA safeguards interphase and mitosis during hematopoiesis in vivo.
Abdul-Sater Z; Cerabona D; Potchanant ES; Sun Z; Enzor R; He Y; Robertson K; Goebel WS; Nalepa G
Exp Hematol; 2015 Dec; 43(12):1031-1046.e12. PubMed ID: 26366677
[TBL] [Abstract][Full Text] [Related]
11. Fanconi anemia repair pathway dysfunction, a potential therapeutic target in lung cancer.
Duan W; Gao L; Aguila B; Kalvala A; Otterson GA; Villalona-Calero MA
Front Oncol; 2014; 4():368. PubMed ID: 25566506
[TBL] [Abstract][Full Text] [Related]
12. BRCA1, FANCD2 and Chk1 are potential molecular targets for the modulation of a radiation-induced DNA damage response in bystander cells.
Burdak-Rothkamm S; Rothkamm K; McClelland K; Al Rashid ST; Prise KM
Cancer Lett; 2015 Jan; 356(2 Pt B):454-61. PubMed ID: 25304378
[TBL] [Abstract][Full Text] [Related]
13. RNAi-mediated knockdown of FANCF suppresses cell proliferation, migration, invasion, and drug resistance potential of breast cancer cells.
Zhao L; Li N; Yu JK; Tang HT; Li YL; He M; Yu ZJ; Bai XF; Zheng ZH; Wang EH; Wei MJ
Braz J Med Biol Res; 2014 Jan; 47(1):24-34. PubMed ID: 24345874
[TBL] [Abstract][Full Text] [Related]
14. Reduced FANCD2 influences spontaneous SCE and RAD51 foci formation in uveal melanoma and Fanconi anaemia.
Gravells P; Hoh L; Solovieva S; Patil A; Dudziec E; Rennie IG; Sisley K; Bryant HE
Oncogene; 2013 Nov; 32(46):5338-46. PubMed ID: 23318456
[TBL] [Abstract][Full Text] [Related]
15. Assessment of FANCD2 nuclear foci formation in paraffin-embedded tumors: a potential patient-enrichment strategy for treatment with DNA interstrand crosslinking agents.
Duan W; Gao L; Zhao W; Leon M; Sadee W; Webb A; Resnick K; Wu X; Ramaswamy B; Cohn DE; Shapiro C; Andreassen PR; Otterson GA; Villalona-Calero MA
Transl Res; 2013 Mar; 161(3):156-64. PubMed ID: 23063585
[TBL] [Abstract][Full Text] [Related]
16. Gene silencing of FANCF potentiates the sensitivity to mitoxantrone through activation of JNK and p38 signal pathways in breast cancer cells.
Li Y; Zhao L; Sun H; Yu J; Li N; Liang J; Wang Y; He M; Bai X; Yu Z; Zheng Z; Mi X; Wang E; Wei M
PLoS One; 2012; 7(8):e44254. PubMed ID: 22952942
[TBL] [Abstract][Full Text] [Related]
17. Fanconi anaemia: from a monogenic disease to sporadic cancer.
Valeri A; Martínez S; Casado JA; Bueren JA
Clin Transl Oncol; 2011 Apr; 13(4):215-21. PubMed ID: 21493181
[TBL] [Abstract][Full Text] [Related]
18. The Fanconi anemia pathway and ICL repair: implications for cancer therapy.
Wang LC; Gautier J
Crit Rev Biochem Mol Biol; 2010 Oct; 45(5):424-39. PubMed ID: 20807115
[TBL] [Abstract][Full Text] [Related]
19. Genetic inactivation of the Fanconi anemia gene FANCC identified in the hepatocellular carcinoma cell line HuH-7 confers sensitivity towards DNA-interstrand crosslinking agents.
Palagyi A; Neveling K; Plinninger U; Ziesch A; Targosz BS; Denk GU; Ochs S; Rizzani A; Meier D; Thasler WE; Hanenberg H; De Toni EN; Bassermann F; Schäfer C; Göke B; Schindler D; Gallmeier E
Mol Cancer; 2010 May; 9():127. PubMed ID: 20509860
[TBL] [Abstract][Full Text] [Related]
20. Hypermethylated SFRP1, but none of other nine genes "informative" for western countries, is valuable for bladder cancer detection in Mainland China.
Sun J; Chen Z; Zhu T; Yu J; Ma K; Zhang H; He Y; Luo X; Zhu J
J Cancer Res Clin Oncol; 2009 Dec; 135(12):1717-27. PubMed ID: 19565266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
